LLC NPF "MIKROKHEM" (responsible for manufacturing and quality control/testing of the batch, excluding batch release; responsible for batch release, excluding quality control/testing of the batch)
UkraineAll drugs from this manufacturer
-
The drug is used to stop bleeding or prevent the risk of bleeding during enhanced clot dissolution (fibrinolysis). It is applied in gastrointestinal bleeding, gynecological issues (e.g., heavy menstruation), dental and other surgical interventions, as well as for controlling bleeding after the administration of special clot-dissolving drugs.
Dosage form: solution for injection
Active substance Dosage tranexamic acid 100 mg/ml ATC: B02AA02
-
The drug is used in the event of a stroke (in the acute phase and for the treatment of consequences), in cases of traumatic brain injury, as well as for impairments of memory, attention, and behavior caused by vascular or degenerative brain disorders.
Dosage form: solution for injection
Active substance Dosage citicoline 250 mg/ml ATC: N06BX06
-
The drug is used in the event of a stroke (in the acute phase and for treating the consequences), in cases of traumatic brain injury, as well as for impairments of memory, attention, and behavior caused by vascular or degenerative brain disorders.
Dosage form: solution for injection
Active substance Dosage citicoline 125 mg/ml ATC: N06BX06